Peter Horby to Time Factors
This is a "connection" page, showing publications Peter Horby has written about Time Factors.
Connection Strength
0.022
-
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
Score: 0.010
-
Insights from clinical research completed during the west Africa Ebola virus disease epidemic. Lancet Infect Dis. 2017 09; 17(9):e280-e292.
Score: 0.008
-
Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006 Jan; 12(1):81-7.
Score: 0.004